HomeBBOT • NASDAQ
add
BridgeBio Oncology Therapeutics Inc
Previous close
$11.93
Day range
$11.85 - $12.35
Year range
$8.50 - $14.87
Market cap
974.26M USD
Avg Volume
175.67K
P/E ratio
61.02
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 49.18M | 150.11% |
Net income | -44.76M | -158.37% |
Net profit margin | — | — |
Earnings per share | -1.03 | — |
EBITDA | -49.11M | -150.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 468.28M | — |
Total assets | 484.79M | — |
Total liabilities | 38.09M | — |
Total equity | 446.70M | — |
Shares outstanding | 79.99M | — |
Price to book | 2.12 | — |
Return on assets | -38.66% | — |
Return on capital | -42.85% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -44.76M | -158.37% |
Cash from operations | -28.77M | -25.23% |
Cash from investing | 40.56M | 1,241.10% |
Cash from financing | 365.44M | — |
Net change in cash | 377.22M | 1,991.03% |
Free cash flow | -17.77M | — |
About
Founded
2016
Headquarters
Website
Employees
81
